Literature DB >> 25904375

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.

Colleen S Kraft1, Angela L Hewlett2, Scott Koepsell3, Anne M Winkler4, Christopher J Kratochvil5, LuAnn Larson6, Jay B Varkey7, Aneesh K Mehta7, G Marshall Lyon7, Rachel J Friedman-Moraco7, Vincent C Marconi7, Charles E Hill4, James N Sullivan8, Daniel W Johnson8, Steven J Lisco8, Mark J Mulligan7, Timothy M Uyeki9, Anita K McElroy9, Tara Sealy9, Shelley Campbell9, Christina Spiropoulou9, Ute Ströher9, Ian Crozier10, Richard Sacra11, Michael J Connor12, Viranuj Sueblinvong13, Harold A Franch14, Philip W Smith2, Bruce S Ribner7.   

Abstract

BACKGROUND: The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management.
METHODS: We report two patients who were transported from West Africa to the United States for treatment of EVD. Both patients received aggressive supportive care measures, as well as an investigational therapeutic (TKM-100802) and convalescent plasma.
RESULTS: While one patient experienced critical illness with multi-organ failure requiring mechanical ventilation and renal replacement therapy, both patients recovered without serious long-term sequelae to date.
CONCLUSIONS: It is unclear what role the experimental drug and convalescent plasma had in the recovery of these patients. Prospective clinical trials are needed to delineate the role of investigational therapies in the care of patients with EVD.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ebola virus; Ebola virus disease; TKM-Ebola; convalescent plasma; convalescent serum

Mesh:

Substances:

Year:  2015        PMID: 25904375      PMCID: PMC4542597          DOI: 10.1093/cid/civ334

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

1.  Clinical care of two patients with Ebola virus disease in the United States.

Authors:  G Marshall Lyon; Aneesh K Mehta; Jay B Varkey; Kent Brantly; Lance Plyler; Anita K McElroy; Colleen S Kraft; Jonathan S Towner; Christina Spiropoulou; Ute Ströher; Timothy M Uyeki; Bruce S Ribner
Journal:  N Engl J Med       Date:  2014-11-12       Impact factor: 91.245

2.  Evaluating Ebola therapies--the case for RCTs.

Authors:  Edward Cox; Luciana Borio; Robert Temple
Journal:  N Engl J Med       Date:  2014-12-03       Impact factor: 91.245

3.  Radiographic imaging for patients with contagious infectious diseases: how to acquire chest radiographs of patients infected with the Ebola virus.

Authors:  William F Auffermann; Colleen S Kraft; Sharon Vanairsdale; G Marshall Lyon; Srini Tridandapani
Journal:  AJR Am J Roentgenol       Date:  2015-01       Impact factor: 3.959

4.  Treatment of Ebola virus disease.

Authors:  Yazdan Yazdanpanah; Jose Ramon Arribas; Denis Malvy
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

5.  Successful delivery of RRT in Ebola virus disease.

Authors:  Michael J Connor; Colleen Kraft; Aneesh K Mehta; Jay B Varkey; G Marshall Lyon; Ian Crozier; Ute Ströher; Bruce S Ribner; Harold A Franch
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

6.  A case of severe Ebola virus infection complicated by gram-negative septicemia.

Authors:  Benno Kreuels; Dominic Wichmann; Petra Emmerich; Jonas Schmidt-Chanasit; Geraldine de Heer; Stefan Kluge; Abdourahmane Sow; Thomas Renné; Stephan Günther; Ansgar W Lohse; Marylyn M Addo; Stefan Schmiedel
Journal:  N Engl J Med       Date:  2014-10-22       Impact factor: 91.245

7.  Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care.

Authors:  Timo Wolf; Gerrit Kann; Stephan Becker; Christoph Stephan; Hans-Reinhardt Brodt; Philipp de Leuw; Thomas Grünewald; Thomas Vogl; Volkhard A J Kempf; Oliver T Keppler; Kai Zacharowski
Journal:  Lancet       Date:  2014-12-19       Impact factor: 79.321

8.  Clinical presentation of patients with Ebola virus disease in Conakry, Guinea.

Authors:  Elhadj Ibrahima Bah; Marie-Claire Lamah; Tom Fletcher; Shevin T Jacob; David M Brett-Major; Amadou Alpha Sall; Nahoko Shindo; William A Fischer; Francois Lamontagne; Sow Mamadou Saliou; Daniel G Bausch; Barry Moumié; Tim Jagatic; Armand Sprecher; James V Lawler; Thierry Mayet; Frederique A Jacquerioz; María F Méndez Baggi; Constanza Vallenas; Christophe Clement; Simon Mardel; Ousmane Faye; Oumar Faye; Baré Soropogui; Nfaly Magassouba; Lamine Koivogui; Ruxandra Pinto; Robert A Fowler
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245

9.  Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.

Authors:  K Mupapa; M Massamba; K Kibadi; K Kuvula; A Bwaka; M Kipasa; R Colebunders; J J Muyembe-Tamfum
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

10.  Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.

Authors:  Thomas W Geisbert; Lisa E Hensley; Elliott Kagan; Erik Zhaoying Yu; Joan B Geisbert; Kathleen Daddario-DiCaprio; Elizabeth A Fritz; Peter B Jahrling; Kevin McClintock; Janet R Phelps; Amy C H Lee; Adam Judge; Lloyd B Jeffs; Ian MacLachlan
Journal:  J Infect Dis       Date:  2006-05-10       Impact factor: 5.226

View more
  79 in total

1.  Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

Authors:  Anita K McElroy; Jessica R Harmon; Timothy D Flietstra; Shelley Campbell; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Christopher J Kratochvil; Peter C Iwen; Philip W Smith; Rafi Ahmed; Stuart T Nichol; Christina F Spiropoulou
Journal:  Clin Infect Dis       Date:  2016-06-27       Impact factor: 9.079

2.  Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.

Authors:  Thomas W Geisbert; James E Strong; Heinz Feldmann
Journal:  J Infect Dis       Date:  2015-06-10       Impact factor: 5.226

3.  Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.

Authors:  Ling Li; Wei Zhang; Yu Hu; Xunliang Tong; Shangen Zheng; Juntao Yang; Yujie Kong; Lili Ren; Qing Wei; Heng Mei; Caiying Hu; Cuihua Tao; Ru Yang; Jue Wang; Yongpei Yu; Yong Guo; Xiaoxiong Wu; Zhihua Xu; Li Zeng; Nian Xiong; Lifeng Chen; Juan Wang; Ning Man; Yu Liu; Haixia Xu; E Deng; Xuejun Zhang; Chenyue Li; Conghui Wang; Shisheng Su; Linqi Zhang; Jianwei Wang; Yanyun Wu; Zhong Liu
Journal:  JAMA       Date:  2020-08-04       Impact factor: 56.272

4.  Peripheral Neuronopathy Associated With Ebola Virus Infection in Rhesus Macaques: A Possible Cause of Neurological Signs and Symptoms in Human Ebola Patients.

Authors:  David X Liu; Donna L Perry; Timothy K Cooper; Louis M Huzella; Randy J Hart; Amanda M W Hischak; John G Bernbaum; Lisa E Hensley; Richard S Bennett
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

5.  Anemia during Hospitalization in the Patients with Ebola Virus Disease.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Iran J Pathol       Date:  2016

6.  The convalescent sera option for containing COVID-19.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

7.  Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa.

Authors:  Saori Sakabe; Brian M Sullivan; Jessica N Hartnett; Refugio Robles-Sikisaka; Karthik Gangavarapu; Beatrice Cubitt; Brian C Ware; Dylan Kotliar; Luis M Branco; Augustine Goba; Mambu Momoh; John Demby Sandi; Lansana Kanneh; Donald S Grant; Robert F Garry; Kristian G Andersen; Juan Carlos de la Torre; Pardis C Sabeti; John S Schieffelin; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

Review 8.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

9.  Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens.

Authors:  Timothy R Southern; Lori D Racsa; César G Albariño; Paul D Fey; Steven H Hinrichs; Caitlin N Murphy; Vicki L Herrera; Anthony R Sambol; Charles E Hill; Emily L Ryan; Colleen S Kraft; Shelley Campbell; Tara K Sealy; Amy Schuh; James C Ritchie; G Marshall Lyon; Aneesh K Mehta; Jay B Varkey; Bruce S Ribner; Kent P Brantly; Ute Ströher; Peter C Iwen; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2015-07-08       Impact factor: 5.948

Review 10.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.